HEPATOCELLULAR CARCINOMA PATIENTS ARE ADVANTAGED IN THE CURRENT BRAZILIAN LIVER TRANSPLANT ALLOCATION SYSTEM. A COMPETING RISK ANALYSIS.

Santiago Rodríguez Alfeu de Medeiros Fleck Marcos Mucenic Cláudio Augusto Marroni Ajácio Bandeira de Mello BrandÃo

Published in: Arquivos de gastroenterologia (2020)

Our results demonstrated that, in our center, patients on the waiting list with HCC have a clear advantage over candidates listed with a calculated MELD score.

Keyphrases

end stage renal disease
chronic kidney disease
ejection fraction
newly diagnosed
prognostic factors
peritoneal dialysis
patient reported outcomes